Episode 2: Reversibility from a Neurologist’s Perspective, Prof Martin Grond

 
 
  • Home
  • Dabigatran and the Role of Reversal Agent
Episode 2: Reversibility from a Neurologist’s Perspective, Prof Martin Grond

Prof. Dr. med. Martin Grond provides a neurologist’s perspective on the reversibility of NOAC therapies and in specific about reversing dabigatran anticoagulant effects using idarucizumab in life threatening emergency situations like ischemic stroke and ICH, based on a retrospective study and real-world experience.

1 month ago
PC-PH-104593 / March 2023
Click read more for Synopsis

Prof. Dr. med. Martin Grond provides a neurologist’s perspective on the reversibility of NOAC therapies and in specific about reversing dabigatran anticoagulant effects using idarucizumab in life threatening emergency situations like ischemic stroke and ICH, based on a retrospective study and real-world experience.

Related Videos for Dabigatran and the Role of Reversal Agent
Episode 3: Reversibility from a Neurologist’s Perspective, Prof Martin Grond

Prof. Dr. med. Martin Grond provides a neurologist’s perspective on the reversibility of NOAC therapies and in specific about reversing dabigatran anticoagulant effects using idarucizumab in life threatening emergency situations like ischemic stroke and ICH, based on a retrospective study and real-world experience.

1 month ago
Idarucizumab Mechanism of Action

DOACs carry a risk of bleeding as with all antithrombotic therapies. A humanized monoclonal antibody was developed to reverse dabigatran anticoagulant effects in rare emergency situations. Let us see the mechanism of action of this antidote, idarucizumab.

1 month ago
Role of Idarucizumab in Neuro-Thrombolysis

Prof. Dr. med. Martin Grond provides a neurologist’s perspective on the reversibility of NOAC therapies and in specific about reversing dabigatran anticoagulant effects using idarucizumab in life threatening emergency situations like ischemic stroke and ICH, based on a retrospective study and real-world experience.

1 month ago
Episode 1: Reversibility from a Neurologist’s Perspective, Prof Martin Grond

Prof. Dr. med. Martin Grond provides a neurologist’s perspective on the reversibility of NOAC therapies and in specific about reversing dabigatran anticoagulant effects using idarucizumab in life threatening emergency situations like ischemic stroke and ICH, based on a retrospective study and real-world experience.

1 month ago
Episode 4: Reversibility from a Neurologist’s Perspective, Prof Martin Grond

Prof. Dr. med. Martin Grond provides a neurologist’s perspective on the reversibility of NOAC therapies and in specific about reversing dabigatran anticoagulant effects using idarucizumab in life threatening emergency situations like ischemic stroke and ICH, based on a retrospective study and real-world experience.

1 month ago
Episode 6: Reversibility from a Neurologist’s Perspective, Prof Martin Grond

Prof. Dr. med. Martin Grond provides a neurologist’s perspective on the reversibility of NOAC therapies and in specific about reversing dabigatran anticoagulant effects using idarucizumab in life threatening emergency situations like ischemic stroke and ICH, based on a retrospective study and real-world experience.

1 month ago
Episode 1: Reversibility from a Cardiologist’s Perspective, Prof Tomaszuk-Kazberuk

Use of direct oral anticoagulants has bridged the need for effective anticoagulation in patients with atrial fibrillation. Professor Anna Tomaszuk-Kazberuk throws light on the efficacy and safety of direct oral anticoagulants and use of idarucizumab to reverse their anticoagulant effect, when needed.

1 month ago
Episode 2: Reversibility from a Cardiologist’s Perspective, Prof Tomaszuk-Kazberuk

Professor Anna Tomaszuk-Kazberuk discusses a case where cardiac surgeons initially refused to operate a patient on anticoagulant treatment and how idarucizumab has paved the way for proceeding with the contemplated procedure.

1 month ago
Episode 3: Reversibility from a Cardiologist’s Perspective, Prof Tomaszuk-Kazberuk

Professor Anna Tomaszuk-Kazberuk elaborates on how the use of idarucizumab changed the opinion of cardiac surgeons from withholding an emergency procedure for an imminent life-threatening condition to performing the same, while the patient was on dabigatran.

1 month ago
Episode 4: Reversibility from a Cardiologist’s Perspective, Prof Tomaszuk-Kazberuk

An elderly lady who had previous stroke and maintained on dabigatran had massive bleeding from her genital tract, as seen by her gynecologist. Professor Anna Tomaszuk-Kazberuk tells us how idarucizumab served as her rescue drug.

1 month ago
Episode 5: Reversibility from a Cardiologist’s Perspective, Prof Tomaszuk-Kazberuk

There are circumstances that may need for emergency reversal of anticoagulation in order to save lives of patients. Professor Anna Tomaszuk-Kazberuk deliberates on the use of idarucizumab by citing different clinical scenarios which were successfully managed with administration of idarucizumab based on her clinical experience.

1 month ago